| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 2.85e-05 | 29 | 6 | 2 | GO:1903779 | |
| GeneOntologyBiologicalProcess | chromosome segregation | 2.16e-04 | 465 | 6 | 3 | GO:0007059 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 3.45e-04 | 100 | 6 | 2 | GO:0061337 | |
| GeneOntologyBiologicalProcess | spindle assembly | 8.04e-04 | 153 | 6 | 2 | GO:0051225 | |
| GeneOntologyBiologicalProcess | spindle organization | 1.71e-03 | 224 | 6 | 2 | GO:0007051 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 2.11e-03 | 249 | 6 | 2 | GO:0008016 | |
| GeneOntologyBiologicalProcess | heart contraction | 3.00e-03 | 298 | 6 | 2 | GO:0060047 | |
| GeneOntologyBiologicalProcess | heart process | 3.22e-03 | 309 | 6 | 2 | GO:0003015 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 3.58e-03 | 326 | 6 | 2 | GO:1903522 | |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | 4.26e-03 | 356 | 6 | 2 | GO:0098813 | |
| GeneOntologyBiologicalProcess | cell cycle process | 5.80e-03 | 1441 | 6 | 3 | GO:0022402 | |
| MousePheno | abnormal Purkinje cell morphology | 3.06e-03 | 204 | 6 | 2 | MP:0000877 | |
| MousePheno | abnormal cerebellar Purkinje cell layer | 3.55e-03 | 220 | 6 | 2 | MP:0000875 | |
| MousePheno | abnormal cerebellar layer morphology | 5.03e-03 | 263 | 6 | 2 | MP:0009956 | |
| MousePheno | ataxia | 5.14e-03 | 266 | 6 | 2 | MP:0001393 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 5.21e-04 | 103 | 5 | 2 | MM15196 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 8.29e-04 | 130 | 5 | 2 | M27454 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.33e-03 | 165 | 5 | 2 | MM15026 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.01e-03 | 203 | 5 | 2 | M5485 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-06 | 200 | 7 | 3 | 36de49593cf6ff1c9229fcceb150c1d68658a360 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-06 | 200 | 7 | 3 | 4c3c11dd5e71ebc3d62264eeaeb71a850b149779 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.00e-04 | 140 | 7 | 2 | 2c44e8cc5190226049be7ebc465d685393e701c4 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Akr1c18_Ntf3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.26e-04 | 149 | 7 | 2 | 1e77f03d2b32f366018fec3462d1b75f6e7febb9 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-1|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 2.67e-04 | 162 | 7 | 2 | deef16449e9ecdc248572a179168c17e21c3f417 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.81e-04 | 166 | 7 | 2 | c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.91e-04 | 169 | 7 | 2 | 16c52a0f6d96ecc1832922fce9b39691849f0d73 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-04 | 175 | 7 | 2 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | CV-Mild-6|Mild / Virus stimulation, Condition and Cluster | 3.12e-04 | 175 | 7 | 2 | c4d530dbb37942427c9cd0a1533faeb6a3a45381 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.12e-04 | 175 | 7 | 2 | f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-04 | 176 | 7 | 2 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-04 | 176 | 7 | 2 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-04 | 176 | 7 | 2 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-04 | 176 | 7 | 2 | d30241fb8119834d6e7b59efec3f92fc7a3d1247 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 3.34e-04 | 181 | 7 | 2 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.71e-04 | 191 | 7 | 2 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-04 | 191 | 7 | 2 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.83e-04 | 194 | 7 | 2 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.83e-04 | 194 | 7 | 2 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.87e-04 | 195 | 7 | 2 | 0feb6ebe7b4b781dec7cfaef844140cfbf84b4b9 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.87e-04 | 195 | 7 | 2 | 2a6f67875cef140b0e6b8401436719675c6b3665 | |
| ToppCell | mLN-B_cell-B_cell_IgG_Plasma|mLN / Region, Cell class and subclass | 3.91e-04 | 196 | 7 | 2 | 03b79f237e4f7ebab46b277d05377569c6342cf7 | |
| ToppCell | mLN-(2)_B_cell-(21)_B_cell_IgG_Plasma|mLN / shred on region, Cell_type, and subtype | 3.91e-04 | 196 | 7 | 2 | e8b12b046d42a58e6f4d9419ab05a5c55e764f34 | |
| ToppCell | mLN-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 3.95e-04 | 197 | 7 | 2 | bd1d01d6c49f68f5c85d84df96c90dd04b9de09b | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-04 | 199 | 7 | 2 | fb580e9321ddf97c73b2e356cd82523db74a38a2 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-04 | 200 | 7 | 2 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-04 | 200 | 7 | 2 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-04 | 200 | 7 | 2 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 4.07e-04 | 200 | 7 | 2 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-04 | 200 | 7 | 2 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 4.07e-04 | 200 | 7 | 2 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-04 | 200 | 7 | 2 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.07e-04 | 200 | 7 | 2 | 16a3685c41194a0a4a772e4eee372160263480e0 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-04 | 200 | 7 | 2 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| Disease | lipid measurement, lipoprotein measurement | 1.91e-04 | 90 | 7 | 2 | EFO_0004529, EFO_0004732 | |
| Disease | remnant cholesterol measurement | 2.75e-04 | 108 | 7 | 2 | EFO_0010815 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 3.75e-04 | 126 | 7 | 2 | EFO_0004611, EFO_0010351 | |
| Disease | polyunsaturated fatty acid measurement | 4.05e-04 | 131 | 7 | 2 | EFO_0010733 | |
| Disease | bipolar I disorder | 4.69e-04 | 141 | 7 | 2 | EFO_0009963 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 9.11e-04 | 197 | 7 | 2 | EFO_0005680 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.08e-03 | 215 | 7 | 2 | EFO_0008317, EFO_0008591 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 1.13e-03 | 220 | 7 | 2 | EFO_0004529, EFO_0008317 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.17e-03 | 224 | 7 | 2 | EFO_0004574, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 1.19e-03 | 225 | 7 | 2 | EFO_0008317, EFO_0010351 | |
| Disease | phospholipids:total lipids ratio | 1.21e-03 | 227 | 7 | 2 | EFO_0020946 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.23e-03 | 229 | 7 | 2 | EFO_0004639, EFO_0008317 | |
| Disease | very low density lipoprotein cholesterol measurement | 1.58e-03 | 260 | 7 | 2 | EFO_0008317 | |
| Disease | testosterone measurement | 2.47e-03 | 1275 | 7 | 3 | EFO_0004908 | |
| Disease | free androgen index | 3.23e-03 | 374 | 7 | 2 | EFO_0007005 | |
| Disease | cognitive decline measurement | 5.38e-03 | 486 | 7 | 2 | EFO_0007710 | |
| Disease | bipolar disorder | 7.51e-03 | 577 | 7 | 2 | MONDO_0004985 | |
| Disease | platelet crit | 1.96e-02 | 952 | 7 | 2 | EFO_0007985 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSPEPDWDNENDILN | 681 | Q01814 | |
| NWESDQPDNPSEENC | 321 | Q9UBG0 | |
| WPEDTDCSQFPEENS | 551 | Q9Y5Q5 | |
| TKQDENDDDDDWNPC | 331 | Q14974 | |
| FDQDEETCWNSDQGP | 31 | Q86WQ0 | |
| CSPQEDSPWQEEEQH | 3201 | Q9P2P6 | |
| PSVLPDNWSCDQNTD | 276 | Q9H0M4 |